More broadly, high-throughput sequencing of post-radiotherapy tumor samples supports a clonal selection model, in which radiation eliminates sensitive tumor clones while enriching for pre-existing subclones harboring mutations in genes like TP53, PTEN, and LKB1. The gene discussed is TP53; the disease is neoplasm.